Sharon M Kelly, Annice Brown, Tracy Agee, Jeffrey Hsu, Nicholas Schweizer, Larry W Chang, Sheree Schwartz, Oluwaseun Falade-Nwulia
{"title":"HIV provider perspectives on opioid use disorder care integration into outpatient HIV care in Baltimore, Maryland: a mixed-methods RE-AIM analysis.","authors":"Sharon M Kelly, Annice Brown, Tracy Agee, Jeffrey Hsu, Nicholas Schweizer, Larry W Chang, Sheree Schwartz, Oluwaseun Falade-Nwulia","doi":"10.1080/09540121.2025.2534538","DOIUrl":null,"url":null,"abstract":"<p><p>Despite the high prevalence of opioid use disorders (OUD) among people with HIV (PWH), treatment among PWH remains low. Integrating OUD care into HIV care may improve OUD outcomes; however, adoption is limited due to multilevel barriers. RESTORE is a low-threshold substance use disorder (SUD) care program integrated into an outpatient HIV-care clinic that provides training and ongoing support for SUD care adoption by HIV providers. This mixed-methods study explored providers' perspectives on barriers and facilitators to RESTORE implementation and adoption of OUD treatment in HIV care. Repeated cross-sectional surveys were administered pre-RESTORE (2019; <i>N</i> = 42) and post-RESTORE implementation (2021; <i>N</i> = 48). In-depth interviews (<i>N</i> = 18) were completed post-implementation. Chi-square analysis assessed differences between pre- and post-implementation responses. Interviews were analyzed using thematic analysis guided by RE-AIM. Acceptability (Acceptability of Intervention Measure [range 4-20], mean = 16.4) and appropriateness (Intervention Appropriateness Measure, mean = 17.9) were high. Adoption of buprenorphine prescribing was high (29.2% post-implementation vs. 4.8% pre-implementation). Comfort managing OUD increased twofold (21.4% to 45.8%; <i>p</i> = 0.02). Inexperience with buprenorphine initiation and time were barriers to adopting OUD treatment. Ongoing mentoring in OUD care was a facilitator. Future research on the integration of OUD care into HIV care should incorporate task-shifting to increase provider-level support for OUD care.</p>","PeriodicalId":48370,"journal":{"name":"Aids Care-Psychological and Socio-Medical Aspects of Aids/hiv","volume":" ","pages":"1332-1345"},"PeriodicalIF":1.2000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Aids Care-Psychological and Socio-Medical Aspects of Aids/hiv","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/09540121.2025.2534538","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/7/25 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"HEALTH POLICY & SERVICES","Score":null,"Total":0}
引用次数: 0
Abstract
Despite the high prevalence of opioid use disorders (OUD) among people with HIV (PWH), treatment among PWH remains low. Integrating OUD care into HIV care may improve OUD outcomes; however, adoption is limited due to multilevel barriers. RESTORE is a low-threshold substance use disorder (SUD) care program integrated into an outpatient HIV-care clinic that provides training and ongoing support for SUD care adoption by HIV providers. This mixed-methods study explored providers' perspectives on barriers and facilitators to RESTORE implementation and adoption of OUD treatment in HIV care. Repeated cross-sectional surveys were administered pre-RESTORE (2019; N = 42) and post-RESTORE implementation (2021; N = 48). In-depth interviews (N = 18) were completed post-implementation. Chi-square analysis assessed differences between pre- and post-implementation responses. Interviews were analyzed using thematic analysis guided by RE-AIM. Acceptability (Acceptability of Intervention Measure [range 4-20], mean = 16.4) and appropriateness (Intervention Appropriateness Measure, mean = 17.9) were high. Adoption of buprenorphine prescribing was high (29.2% post-implementation vs. 4.8% pre-implementation). Comfort managing OUD increased twofold (21.4% to 45.8%; p = 0.02). Inexperience with buprenorphine initiation and time were barriers to adopting OUD treatment. Ongoing mentoring in OUD care was a facilitator. Future research on the integration of OUD care into HIV care should incorporate task-shifting to increase provider-level support for OUD care.